For the brief, AHRQ examined readmission trends and costs using the 2010-16 Nationwide Readmissions Database, which includes data on hospital patients 1 year and older readmitted for any cause within 30 days of first admission. AHRQ focused on readmissions for 18 of the 21 principal diagnosis categories listed in ICD-10’s diagnosis coding system. Three categories were excluded for lack of data, or because they involved planned aftercare.
The average readmission cost for any diagnosis in 2016 was $14,400.
Eighteen diagnoses and their average readmission costs:
1. Congenital malformations — $19,000 in average readmission costs for 2016
2. Neoplasms — $17,900
3. Infectious/parasitic diseases — $16,700
4. Injury, poisoning, external causes — $16,500
5. Circulatory system diseases — $15,900
6. Blood diseases — $15,700
7. Musculoskeletal system diseases — $15,000
8. Respiratory system diseases — $14,500
9. Nervous system diseases — $14,400
10. Digestive system diseases — $14,400
11. Eye/adnexa diseases — $14,000
12. Conditions not elsewhere classified — $13,800
13. Endocrine/metabolic diseases — $13,500
14. Genitourinary system diseases — $13,200
15. Skin diseases — $13,200
16. Ear/mastoid process diseases — $12,900
17. Mental/behavioral disorders — $8,200
18. Pregnancy/childbirth — $7,000
More articles on rankings and ratings:
National healthcare scorecard: Where does your state rank?
States ranked by percentage of nursing homes cited for care deficiencies
10 best, worst states to find a job
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
